International Journal of
Genetics and Molecular Biology

  • Abbreviation: Int. J. Genet. Mol. Biol.
  • Language: English
  • ISSN: 2006-9863
  • DOI: 10.5897/IJGMB
  • Start Year: 2009
  • Published Articles: 132

Full Length Research Paper

First detection of the hemizygote frameshift variant of the DMD gene in a 13-year-old patient affected by dystrophinopathy (Duchenne DMD and Becker BMD) at Saint Camille Hospital of Ouagadougou, Burkina Faso: Case report

Théodora Mahoukèdè Zohoncon
  • Théodora Mahoukèdè Zohoncon
  • Saint Camille Hospital of Ouagadougou (HOSCO), 09 BP 444 Ouagadougou 09, Burkina Faso.
  • Google Scholar
Paul Ouedraogo
  • Paul Ouedraogo
  • Saint Camille Hospital of Ouagadougou (HOSCO), 09 BP 444 Ouagadougou 09, Burkina Faso.
  • Google Scholar
Marius Belemgnegre
  • Marius Belemgnegre
  • Saint Camille Hospital of Ouagadougou (HOSCO), 09 BP 444 Ouagadougou 09, Burkina Faso.
  • Google Scholar
Abdoul Karim Ouattara
  • Abdoul Karim Ouattara
  • Laboratory of Molecular Biology and Genetics (LABIOGENE), University Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso.
  • Google Scholar
L. Bienvenue Tingueri
  • L. Bienvenue Tingueri
  • Saint Camille Hospital of Ouagadougou (HOSCO), 09 BP 444 Ouagadougou 09, Burkina Faso.
  • Google Scholar
Jacques Simpore
  • Jacques Simpore
  • Saint Camille Hospital of Ouagadougou (HOSCO), 09 BP 444 Ouagadougou 09, Burkina Faso.
  • Google Scholar


  •  Received: 04 January 2020
  •  Published: 29 February 2020

References

Bakker E, Jennekens FG, De Visser M, Wintzen AR (1997). Duchenne and Becker muscular dystrophies In: Diagnostic criteria for neuromuscular disorders, pp. 1-4.

 

Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, Hor K, Judge DP, Kinnett K, McNally EM, Raman S, Thompson WR, Wagner KR, Olson AK (2018). Cardiac management of the patient with duchenne muscular dystrophy. Pediatrics 142(2):S72-S81.
Crossref

 
 

Bushby KM, Gardner-Medwin D, Nicholson LV, Johnson MA, Haggerty ID, Cleghorn NJ, Harris JB, Bhattacharya SS (1993). The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities. Journal of Neurology 240(2):105-112.
Crossref

 
 

Campbell KP (1995). Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80(5):675-679.
Crossref

 
 

Cripe LH, Tobias JD (2013). Cardiac considerations in the operative management of the patient with Duchenne or Becker muscular dystrophy. Pediatric Anesthesia 23(9):777-784.
Crossref

 
 

Deburgrave N, Daoud F, Llense S, Barbot JC, Recan D, Peccate C, Burghes AH, Beroud C, Garcia L, Kaplan JC, Chelly J, Leturcq F (2007). Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene. Human Mutation 28(2):183-195.
Crossref

 
 

Gospe SM, Lazaro RP, Lava NS, Grootscholten PM, Scott MO, Fischbeck KH (1989). Familial X-linked myalgia and cramps: a nonprogressive myopathy associated with a deletion in the dystrophin gene. Neurology 39(10):1277-1280.
Crossref

 
 

Kwiatkowska J, Meyer-Szary J, Bazgier M, Fijałkowska J, Wierzba J, Glińska A, Dorniak K (2020). Left ventricular volumes and function affected by myocardial fibrosis in patients with Duchenne and Becker muscular dystrophies: a preliminary magnetic resonance study. Kardiologia Polska, pp. 1-10.
Crossref

 
 

Melacini P, Fanin M, Danieli GA, Villanova C, Martinello F, Miorin M, Freda MP, Miorelli M, Mostacciuolo ML, Fasoli G, Angelini C, Dalla Volta S (1996). Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. Circulation 94(12):3168-3175.
Crossref

 
 

Mori-Yoshimura M, Mitsuhashi S, Nakamura H, Komaki H, Goto K, Yonemoto N, Takeuchi F, Hayashi YK, Murata M, Takahashi Y, Nishino I, Takeda S, Kimura E (2018). Characteristics of Japanese Patients with Becker Muscular Dystrophy and Intermediate Muscular Dystrophy in a Japanese National Registry of Muscular Dystrophy (Remudy): Heterogeneity and Clinical Variation. Journal of Neuromuscular Diseases 5(2):193-203.
Crossref

 
 

Mornet D, Rivier F (2017). What future for dystrophin? Les cahiers de myologie (15):17-21.
Crossref

 
 

Muntoni F, Torelli S, Ferlini A (2003). Dystrophin and mutations: one gene, several proteins, multiple phenotypes. The Lancet Neurology 2(12):731-740.
Crossref

 
 

Nakamura A (2015). X-Linked Dilated Cardiomyopathy: A Cardiospecific Phenotype of Dystrophinopathy. Pharmaceuticals (Basel) 8(2):303-320.
Crossref

 
 

Ortez C, Natera de Benito D, Carrera Garcia L, Exposito J, Nolasco G, Nascimento A (2019). Advances in the treatment of Duchenne muscular dystrophy. Medicina 79(3):77-81.

 
 

Péréon Y, Mercier S, Magot A (2015). Duchenne muscular dystrophy pathophysiology. Archives de pédiatrie. 22(12Suppl1):12S18-23
Crossref

 
 

Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL (1993). Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Academy of Sciences of the United States of America 90(8):3710-3714.
Crossref

 
 

Rahimov F, Kunkel LM (2013). The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy. Journal of Cell Biology 201(4):499-510.
Crossref

 
 

Serrano AL, Munoz-Canoves P (2017). Fibrosis development in early-onset muscular dystrophies: Mechanisms and translational implications. Seminars in cell and developmental biology 64:181-190.
Crossref

 
 

Straathof CS, Van Heusden D, Ippel PF, Post JG, Voermans NC, De Visser M, Brusse E, Van Den Bergen JC, Van Der Kooi AJ, Verschuuren JJ, Ginjaar HB (2015). Diagnosis of becker muscular dystrophy: Results of Re-analysis of DNA samples. Muscle and Nerve 53(1):44-48.
Crossref